What is Retatrutide?
Retatrutide (LY3437943) is a next-generation triple-agonist peptide developed by Eli Lilly that targets three key metabolic receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This triple mechanism of action sets it apart from dual-agonists like tirzepatide (Mounjaro/Zepbound) and single-agonists like semaglutide (Ozempic/Wegovy).
In the landmark TRIUMPH-4 Phase 3 clinical trial, participants achieved an average of 28.7% body weight reduction over 68 weeks — making retatrutide the most effective weight loss peptide studied to date.
Key Benefits:
- Significant appetite suppression via GLP-1 receptor activation
- Enhanced fat burning through glucagon receptor activation (unique to retatrutide)
- Improved glucose regulation and insulin sensitivity via GIP
- Once-weekly subcutaneous dosing convenience
- Potential cardiovascular and metabolic health improvements
- Superior weight loss results compared to tirzepatide and semaglutide in trials
Current Status: Retatrutide is in Phase 3 clinical trials (TRIUMPH program) as of 2026. It has not yet received FDA approval. Multiple trials are ongoing for obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH/NASH).
How Does Retatrutide Work? The Triple-Agonist Mechanism
Understanding why retatrutide is so effective requires understanding its three targets:
GLP-1 Receptor Activation
GLP-1 (glucagon-like peptide-1) is a hormone released in your gut after eating. It signals your brain to feel full, slows stomach emptying, and stimulates insulin release. This is the same receptor targeted by semaglutide and liraglutide. Retatrutide's GLP-1 activation drives the core appetite suppression effect.
GIP Receptor Activation
GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that enhances insulin secretion and plays a role in fat metabolism. Tirzepatide was the first drug to combine GLP-1 and GIP activation, and the addition of GIP appears to amplify weight loss beyond GLP-1 alone. Retatrutide includes this same dual benefit.
Glucagon Receptor Activation — The Game Changer
This is what makes retatrutide unique. Glucagon is your body's primary fat-burning hormone. It:
- Increases energy expenditure (your body burns more calories at rest)
- Promotes lipolysis (breakdown of stored fat)
- Reduces liver fat accumulation
- Enhances thermogenesis
The addition of glucagon receptor activation is believed to be the reason retatrutide produces significantly greater weight loss than tirzepatide or semaglutide, which do not activate glucagon receptors.
Clinical Trial Results
Phase 2 Trial (NEJM, 2023)
The Phase 2 trial published in the New England Journal of Medicine showed dose-dependent weight loss:
- 1mg dose: 8.7% weight loss at 48 weeks
- 4mg dose: 17.1% weight loss at 48 weeks
- 8mg dose: 22.8% weight loss at 48 weeks
- 12mg dose: 24.2% weight loss at 48 weeks
- Placebo: 2.1% weight loss
TRIUMPH-4 Phase 3 Trial (2025-2026)
The pivotal Phase 3 TRIUMPH-4 trial confirmed and exceeded Phase 2 results:
- Average weight loss: 28.7% at the highest dose over 68 weeks
- Clinically meaningful improvements in metabolic markers
- Acceptable safety profile consistent with the GLP-1 agonist class
These results surpass tirzepatide's Phase 3 results (22.5% at highest dose) and semaglutide's (16% at highest dose).
Reconstitution Guide
What You'll Need
- Retatrutide 10mg vial (lyophilized powder)
- Bacteriostatic water (BAC water)
- Insulin syringes (1mL/100 unit)
- Alcohol swabs
- Clean workspace
Step-by-Step Mixing Instructions
- Prepare your workspace — Clean the area and wash your hands thoroughly
- Warm to room temperature — Allow both the peptide vial and BAC water to reach room temperature before mixing (15-20 minutes out of refrigerator)
- Clean the vial tops — Swab both vial tops with alcohol and let dry for 10 seconds
- Draw the BAC water — For a 10mg vial, draw 2mL (200 units) of bacteriostatic water
- Inject slowly — Insert needle into the Retatrutide vial and inject water slowly down the inside wall of the vial (not directly onto the powder)
- Swirl gently — DO NOT SHAKE. Gently swirl the vial in circles until the powder is completely dissolved. This may take 2-3 minutes.
- Inspect — The solution should be clear with no particles or cloudiness. If cloudy, continue gentle swirling. If particles remain after 5 minutes, discard the vial.
Resulting Concentration: 10mg in 2mL = 5mg/mL (5,000mcg/mL)
Alternative Reconstitution for Higher Doses
If you plan to reach maintenance doses of 8-12mg, consider reconstituting with only 1mL of BAC water for a concentration of 10mg/mL. This allows larger doses in a single injection without exceeding comfortable injection volumes.
| Reconstitution Volume | Concentration | 4mg Dose Volume | 8mg Dose Volume | 12mg Dose Volume |
|---|---|---|---|---|
| 2mL | 5mg/mL | 0.8mL (80 units) | 1.6mL (160 units) | Split required |
| 1mL | 10mg/mL | 0.4mL (40 units) | 0.8mL (80 units) | 1.2mL (120 units) |
Dosing Protocol
Retatrutide requires a gradual dose escalation (titration) to minimize gastrointestinal side effects. Do not skip ahead in the titration schedule — rushing doses is the #1 cause of severe nausea.
Titration Schedule
| Week | Dose | Volume (2mL reconstitution) | Volume (1mL reconstitution) |
|---|---|---|---|
| 1-4 | 1mg | 0.2mL (20 units) | 0.1mL (10 units) |
| 5-8 | 2mg | 0.4mL (40 units) | 0.2mL (20 units) |
| 9-12 | 4mg | 0.8mL (80 units) | 0.4mL (40 units) |
| 13-16 | 6mg | 1.2mL (120 units) | 0.6mL (60 units) |
| 17-20 | 8mg | 1.6mL (160 units) | 0.8mL (80 units) |
| 21+ | 8-12mg | Maintenance dose | 0.8-1.2mL |
Best Time of Day to Take Retatrutide
Most users inject retatrutide in the morning or early afternoon. Key considerations:
- Morning injection is preferred by most users — allows any nausea to pass during the day rather than disrupting sleep
- Consistency matters more than timing — pick a time and stick with it each week
- Avoid injecting before large meals — the appetite suppression effect peaks 24-48 hours after injection
- Some users prefer evening injection if they experience fatigue as a side effect
Dosing Schedule
- Frequency: Once weekly (every 7 days)
- Same day each week: Pick a day and stick to it
- Missed dose: If within 5 days of your scheduled dose, take it. If more than 5 days late, skip and resume your next scheduled dose.
- Dose adjustment: If side effects are intolerable, stay at the current dose for an additional 4 weeks before escalating. You can also step back one dose level temporarily.
Injection Guide
Injection Sites
Rotate between these subcutaneous injection sites:
- Abdomen — 2 inches away from the navel (most common and typically least painful)
- Thigh — Front or outer thigh, midway between hip and knee
- Upper arm — Back of the arm (may need assistance)
Rotate sites weekly to prevent tissue irritation, bruising, and lipodystrophy (fat tissue changes at injection site).
Injection Technique
- Clean the injection site with an alcohol swab and let dry
- Pinch a fold of skin between thumb and forefinger
- Insert the needle at a 45-90 degree angle (90° for most body compositions)
- Inject slowly and steadily over 5-10 seconds
- Hold for 5-10 seconds after the plunger is fully depressed before withdrawing
- Release the skin fold and withdraw the needle
- Do not rub the injection site — apply gentle pressure with a clean cotton ball if needed
Storage Instructions
Lyophilized (Powder) Form
- Short-term (1-2 months): Refrigerate at 2-8°C (36-46°F)
- Long-term: Freeze at -20°C (-4°F) for up to 24 months
- Protect from light and moisture
- Keep in original packaging until ready to reconstitute
Reconstituted Solution
- Refrigerate immediately at 2-8°C (36-46°F)
- Use within 4-6 weeks of reconstitution
- Never freeze reconstituted solution
- Keep away from direct light
- Discard if solution becomes cloudy, discolored, or contains particles
- Do not use past 6 weeks even if solution appears clear
Managing Side Effects
Common Side Effects
The most common side effects are gastrointestinal and typically occur during dose escalation phases:
- Nausea (most common — affects 40-60% of users, usually mild-moderate)
- Decreased appetite (intended effect, but can be pronounced)
- Diarrhea or constipation
- Mild abdominal discomfort or bloating
- Fatigue (usually in the first 1-2 days after injection)
- Injection site reactions (mild redness or itching)
Tips to Minimize Side Effects
For Nausea:
- Eat smaller, more frequent meals (5-6 small meals vs 3 large ones)
- Avoid greasy, fatty, fried, and heavily spiced foods
- Stay well hydrated — sip water throughout the day
- Try ginger tea, ginger chews, or peppermint tea
- Eat bland foods when nauseous (bananas, rice, toast, crackers)
- Avoid eating large meals late at night
- Consider anti-nausea remedies (ginger supplements, vitamin B6)
For Constipation:
- Increase fiber intake gradually
- Drink plenty of water (minimum 2-3 liters daily)
- Consider a gentle fiber supplement (psyllium husk)
- Stay physically active
General Tips:
- Follow the titration schedule strictly — do not rush
- Don't increase dose if still experiencing significant side effects at current dose
- Stay hydrated (this cannot be overstated)
- Avoid alcohol, especially during dose increases
- Monitor for dehydration signs if experiencing diarrhea
When Side Effects Typically Improve
- Most GI symptoms peak in the first 2-3 days after each injection
- Symptoms at a given dose usually improve within 2-4 weeks
- Side effects may briefly return when increasing to the next dose tier
- By 12+ weeks at maintenance dose, most users report minimal side effects
What to Expect: Week-by-Week Timeline
Week 1-2 (1mg Dose)
- Mild appetite suppression begins — you may notice feeling full sooner
- Some users experience mild nausea, especially in the first 24-48 hours
- Weight change is typically minimal (0-2 lbs) — your body is adjusting
- Allow your body time to adapt before expecting significant changes
Week 4-8 (2mg Dose)
- Appetite suppression becomes more noticeable and consistent
- Weight loss typically begins — expect 2-5% body weight reduction by week 8
- Food preferences may shift — cravings for high-calorie foods often decrease
- Side effects often peak when transitioning from 1mg to 2mg
- Energy levels may begin to improve as metabolic changes take effect
Week 8-12 (4mg Dose)
- This is where significant changes become visible
- Weight loss accelerates — many users report 5-10% total body weight loss
- Waist circumference reduction becomes noticeable
- Blood sugar and metabolic markers often show improvement
- Your relationship with food begins to fundamentally change
Week 12-20 (6-8mg Dose)
- Consistent, steady weight loss continues
- Most users are well-adapted to side effects at this point
- Total weight loss typically reaches 15-20% of starting body weight
- Improvements in energy, mobility, and overall well-being
- Many users report improved sleep quality
- Lab work often shows improved cholesterol, triglycerides, and HbA1c
Week 20+ (8-12mg Maintenance)
- Weight loss may continue at a slower rate or reach a plateau
- Total weight loss of 20-28% is typical at maintenance doses
- Focus shifts to maintenance and lifestyle optimization
- Side effects are typically minimal at stable doses
- Some users find they can maintain results at 8mg rather than escalating to 12mg
Important Warnings
Seek immediate medical attention if you experience:
- Severe, persistent abdominal pain (may indicate pancreatitis)
- Signs of allergic reaction (rash, difficulty breathing, facial swelling)
- Severe vomiting that won't stop or prevents keeping fluids down
- Signs of low blood sugar (shakiness, sweating, confusion) — especially if diabetic
- Signs of dehydration (dark urine, dizziness, rapid heartbeat)
- Vision changes (rare but reported with GLP-1 class)
Contraindications:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- History of pancreatitis
- Pregnancy or breastfeeding (discontinue at least 2 months before planned conception)
- Severe gastroparesis
- History of severe hypoglycemia (if diabetic)
Stacking Considerations
Retatrutide may be used alongside certain compounds for complementary benefits:
- NAD+ — For enhanced cellular energy, metabolism, and recovery support
- BPC-157 — For gut health support (may help mitigate GI side effects)
- GHK-Cu — For skin elasticity support during rapid weight loss
- L-Carnitine — May support fat oxidation alongside retatrutide's metabolic effects
Note: Always consult with a healthcare provider before combining compounds. Do not stack retatrutide with other GLP-1 agonists (semaglutide, tirzepatide, liraglutide) due to overlapping mechanisms and increased risk of severe GI side effects.
Frequently Asked Questions
How long does it take for retatrutide to start working? Most users notice appetite suppression within the first week. Measurable weight loss typically begins within 2-4 weeks. Significant results become visible by weeks 8-12.
Can I drink alcohol on retatrutide? Alcohol is not strictly prohibited, but it is strongly discouraged — especially during dose escalation. Retatrutide slows gastric emptying, which means alcohol hits harder and faster. Many users report dramatically reduced alcohol tolerance.
What happens if I stop taking retatrutide? Weight regain is possible after discontinuation, as with all weight loss medications. The rate of regain varies. Lifestyle changes made during treatment (diet, exercise habits) can help maintain results. Some users taper gradually rather than stopping abruptly.
Is retatrutide better than tirzepatide or semaglutide?
Clinical trial data suggests retatrutide produces greater weight loss than both tirzepatide (22.5%) and semaglutide (16%). However, individual responses vary. Read our detailed comparison guide for a full breakdown.
How should I adjust my diet on retatrutide? Focus on protein-rich foods to preserve muscle mass during weight loss (aim for 0.7-1g protein per pound of body weight). Eat nutrient-dense foods since your overall intake will decrease. Stay hydrated. Avoid empty calories — your reduced appetite means every meal counts more.
Related Guides
For more detailed information on specific topics, explore our retatrutide guide series:
- Retatrutide Dosage Calculator — Personalized dosing by body weight with volume calculations
- Retatrutide Results: What to Expect — Detailed timeline with clinical data and realistic expectations
- Retatrutide Side Effects Guide — Complete side effect management strategies
- Retatrutide vs Tirzepatide — Head-to-head comparison of the two most effective weight loss peptides
Research Disclaimer
Retatrutide (LY3437943) is an investigational compound currently in Phase 3 clinical trials conducted by Eli Lilly and Company. It has not been approved by the FDA or Health Canada for any indication. The information in this guide is compiled from published clinical trial data, peer-reviewed research, and established pharmacological principles. This guide is for educational and informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new supplement or medication regimen.
